Furthermore, lipid metabolism disorder often occurred in gout patients, which caused kidney damage (Figure 3(c)) in gout patients, and recent study has shown that IL-33 plays a protective role in atherosclerosis. This evidence concerns the gene IL33 and Nephropathy.